| 证券代码 | JNP.O |
| 证券名称 | Juniper Pharmaceuticals Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2004-02-13 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Juniper Pharmaceuticals, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 33 Arch Street, Suite 3110, Boston Massachusetts, USA |
| 成立日期 | 1986-12 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.juniperpharma.com |
| 电话 | +1 (617) 639-1500 |
| 传真 | - |
| 公司简介 | Juniper Pharmaceuticals, Inc. is focused on developing therapeutics that address unmet medical needs in women’s health. The Company is advancing a pipeline of proprietary product candidates that leverage its differentiated intravaginal ring technology and when appropriate the 505(b)(2) regulatory pathway. Targeted product development investments are enabled by Juniper’s core operating business: the CRINONE (progesterone gel) franchise and Juniper Pharma Services, which provides high-end fee-for-service pharmaceutical development and clinical trials manufacturing to clients. |